Telmisartan, ramipril, or both in patients at high risk for vascular events (2008)
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS VASCULARES (TRATAMENTO), DIABETES MELLITUS, ANGIOTENSINAS
ABNT
MARIN-NETO, José Antônio. Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine, v. 258, n. 15, p. 1547-1559, 2008Tradução . . Acesso em: 05 ago. 2024.APA
Marin-Neto, J. A. (2008). Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine, 258( 15), 1547-1559.NLM
Marin-Neto JA. Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine. 2008 ; 258( 15): 1547-1559.[citado 2024 ago. 05 ]Vancouver
Marin-Neto JA. Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine. 2008 ; 258( 15): 1547-1559.[citado 2024 ago. 05 ]